North America Clinical Laboratory Services Market is expected to grow with the CAGR of 7.3% in the forecast period of 2021 to 2028. The years considered for study are as mentioned below.
Access Full Report @ https://www.databridgemarketresearch.com/pt/reports/north-america-clinical-laboratory-services-market
North America clinical laboratory services market is a highly consolidated market, which includes specific number of key players. The market has witnessed increased strategic developments owing to favorable market scenario.
The major players dealing in the North America clinical laboratory services market are introducing a wide range of products along with adopting strategic initiatives such as acquisition, agreement, business expansion, award, and recognition into the market. This helped the companies to maximize the sales with enhanced product portfolio.
For instance:
- In July 2021, Laboratory Corporation of America, a globally leading company in life sciences, declared the accessibility of therascreen KRAS PCR Mutation Analysis, which is a companion diagnostic for identifying patients having non-small cell lung cancer (NSCLC), becoming a novel therapy alternative developed by Amgen. The access of the service by the company has lead to expanding companies diagnostic tests testing portfolio, after the approval of FDA for breast, lung, colorectal, bladder and other cancers.
Mayo Foundation for Medical Education and Research is dominating the player in the North America clinical laboratory services market. Some of the major players operating in the North America clinical laboratory services market are Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, DaVita Inc., Eurofins Scientific, UNILABS, SYNLAB International GmbH, H.U. Groups Holdings, Inc., Sonic Healthcare Limited, ACM Global Laboratories, Amedes Holding GmbH, LifeLabs, Abbott, Charles River Laboratories, Siemens Healthcare GmbH, BioReference Laboratories (A subsidiary of Opko Health, Inc.), NeoGenomics Laboratories, KingMed Diagnostics Group Co., Ltd., Genomic Health, ARUP Laboratories among others.
Mayo Foundation for Medical Education and Research (MFMER)
Mayo Foundation for Medical Education and Research (MFMER) is headquartered in Minnesota, U.S. The company focuses on providing wellbeing and health to each patient by the means of integrated clinical practices. Their Service categories are Light Protection Tests, Microbiology Culture Tests, Category A Infectious Substances and Microbiology Culture Tests is the focused category.
For instance,
- In June 2021, Mayo Clinic and Thermo Fisher Scientific made a partnership for providing innovative solutions to patients by accelerating clinical validation and commercialization of selected next-generation sequencing (NGS), mass spectrometry and immunology diagnostic tools. This partnership has helped the company in terms of adding innovative products and services in clinical validation.
The company has presence North America, Europe, Middle East and Africa.
Laboratory Corporation of America Holding
Laboratory Corporation of America Holding founded in 1995 and is headquartered in North Carolina, U.S. The company focuses on improving the health and lives by providing world-class diagnostics accelerating the availability of innovative medicines by using technology to deliver best care for the patients and the clients. Their business segment includes LabCorp Diagnostics (LCD) and Covance Drug Development (CDD) of which LabCorp Diagnostics (LCD) and Covance Drug Development (CDD) is the market focus categories. Their service categories are Provider Services, Research, Analysis Services, Lead Optimization, Product Testing, Manufacturing Support, Toxicology, Safety Assessment and Testing, Consulting & Partnering, Clinical Development, Informatics, Clinical Testing, and Commercialization of which Clinical Testing, Provider Services is the market focused categories.
For instance,
- In November 2020, Laboratory Corporation of America, globally leading life sciences company which is concentrated on advancing health and guiding patient care choices, and BML, which is a leading Japanese provider of clinical laboratory testing services, declared an expansion agreement for providing development and distribution of companion diagnostics in Japan. This partnership of company with BML will further expand companies reach in japan and benefit its biopharmaceutical clients who want global solution for precision medicine, with an ultimate goal for improving health and lives of patients globally.
The company has presence in U.S. Their subsidiaries Covance (U.S.), Pathology Associates Medical Laboratories (U.S.), Sequenom (U.S.), Medtox Laboratories, Inc (U.S.), Esoterix Inc (U.S.) among others.
Quest Diagnostics Incorporated
Quest Diagnostics Incorporated was founded in 1990 with its headquartered in New Jersey, U.S. The company focuses on offering innovations and insights that helps to improve the life of patients in a better way. Their business segment is DIS Business, DS Business of which DIS Business, DS Business is focus categories. Their service categories are Anatomic Pathology Services, Bioanalytical Laboratories, Biomarker Services, Biotech Laboratory Solutions, Central Laboratories, Companion Diagnostics, Flow Cytometry Services, Genomics Laboratories, Vaccines of which Bioanalytical Laboratories, Biotech Laboratory Solutions, Central Laboratories is the focused category.
For instance,
- In July 2019, Quest Diagnostics Incorporated launched Lyme Disease Tests through QuestDirect. It helps to fight with bacterium that causes lyme diseases. The launch was helpful in knowing that an individual has been bitten by the lyme diseases and can purchase tests for the identification of Lyme tests. With the launch of this test, company will expand its product portfolio as well as grow sale & revenue.
The company has presence in U.S. India, Ireland, and Mexico.
